Roberts Christopher D.
Chief Scientific Officer at BDTX
- Sold, on record
- $825k
- Dollars the filings state
- Form 4 sales
- 10
- Latest May 3, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BDTXBlack Diamond Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BDTXUnusualNov 3, 2020 2020
Sold 2,500 shares at $31.95 ($80k)
Roberts Christopher D., Chief Scientific Officer
Sold 100% of holdings ($80k position)0 shares leftFiling
- 2 Form 4 sale BDTXUnusualNov 11, 2020 +8 days
Sold 5,000 shares at $34.90 ($175k)
Roberts Christopher D., Chief Scientific Officer
Sold 100% of holdings ($175k position)0 shares left2x usual sizeFiling
- 3 Form 4 sale BDTXUnusualDec 3, 2020 +22 days
Sold 2,500 shares at $32.42 ($81k)
Roberts Christopher D., Chief Scientific Officer
Sold 100% of holdings ($81k position)0 shares left1x usual sizeFiling
- 4 Form 4 sale BDTXUnusualJan 4, 2021 +32 days
Sold 2,500 shares at $31.41 ($79k)
Roberts Christopher D., Chief Scientific Officer
Sold 43.9% of holdings ($179k position)3,200 shares left1x usual sizeFiling
- 5 Form 4 sale BDTXUnusualFeb 3, 2021 +30 days
Sold 2,500 shares at $25.35 ($63k)
Roberts Christopher D., Chief Scientific Officer
Sold 43.9% of holdings ($144k position)3,200 shares left1x usual sizeFiling
- 6 Form 4 sale BDTXUnusualMar 3, 2021 +28 days
Sold 2,500 shares at $26.10 ($65k)
Roberts Christopher D., Chief Scientific Officer
Sold 43.9% of holdings ($149k position)3,200 shares left1x usual sizeFiling
- 7 Form 4 sale BDTXUnusualApr 5, 2021 +33 days
Sold 2,500 shares at $25.54 ($64k)
Roberts Christopher D., Chief Scientific Officer
Sold 43.9% of holdings ($146k position)3,200 shares left1x usual sizeFiling
- 8 Form 4 sale BDTXUnusualMay 3, 2021 +28 days
Sold 2,500 shares at $26.64 ($67k)
Roberts Christopher D., Chief Scientific Officer
Sold 43.9% of holdings ($152k position)3,200 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 3, 2021 | May 5, 2021 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $67k | 43.9% | Unusual | SEC |
| Apr 5, 2021 | Apr 7, 2021 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $64k | 43.9% | Unusual | SEC |
| Mar 3, 2021 | Mar 4, 2021 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $65k | 43.9% | Unusual | SEC |
| Feb 3, 2021 | Feb 4, 2021 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $63k | 43.9% | Unusual | SEC |
| Jan 4, 2021 | Jan 6, 2021 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $79k | 43.9% | Unusual | SEC |
| Dec 3, 2020 | Dec 4, 2020 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $81k | 100.0% | Unusual | SEC |
| Nov 11, 2020 | Nov 13, 2020 | BDTX | Chief Scientific Officer | Form 4 sale | 5,000 | $175k | 100.0% | Unusual | SEC |
| Nov 3, 2020 | Nov 4, 2020 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $80k | 100.0% | Unusual | SEC |
| Oct 5, 2020 | Oct 7, 2020 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $78k | 100.0% | Unusual | SEC |
| Sep 3, 2020 | Sep 4, 2020 | BDTX | Chief Scientific Officer | Form 4 sale | 2,500 | $74k | 100.0% | Unusual | SEC |